124 related articles for article (PubMed ID: 3207466)
1. Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.
Dornish JM; Undheim K; Pettersen EO; Oftebro R; Laland SG
Anticancer Drug Des; 1988 Dec; 3(3):191-8. PubMed ID: 3207466
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cis-dichlorodiammineplatinum (II)-induced cytotoxicity by methylglyoxal.
Dornish JM; Pettersen EO
Anticancer Res; 1989; 9(4):1137-42. PubMed ID: 2817795
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.
Dornish JM; Pettersen EO; Oftebro R
Br J Cancer; 1987 Sep; 56(3):273-8. PubMed ID: 3663475
[TBL] [Abstract][Full Text] [Related]
5. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
Melvik JE; Pettersen EO
Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
[TBL] [Abstract][Full Text] [Related]
6. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
[TBL] [Abstract][Full Text] [Related]
7. Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.
Dornish JM; Melvik JE; Pettersen EO
Anticancer Res; 1986; 6(4):583-8. PubMed ID: 3752939
[TBL] [Abstract][Full Text] [Related]
8. Sulfhydryl-related reduction of the mitotic inhibition and cell inactivation induced by pyrimidine analogs.
Nygaard ME; Dornish JM; Pettersen EO; Oftebro R
Anticancer Drug Des; 1988 Jun; 3(1):15-24. PubMed ID: 3382505
[TBL] [Abstract][Full Text] [Related]
9. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
10. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
[TBL] [Abstract][Full Text] [Related]
11. Synergistic cell inactivation of human NHIK 3025 cells by cinnamaldehyde in combination with cis-diamminedichloroplatinum(II).
Dornish JM; Pettersen EO; Oftebro R
Cancer Res; 1988 Feb; 48(4):938-42. PubMed ID: 3338086
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
Bergerat JP; Green C; Drewinko B
Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
[TBL] [Abstract][Full Text] [Related]
13. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
14. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo.
Ambrose KR; Lowrey JS
Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818
[TBL] [Abstract][Full Text] [Related]
15. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
Roberts JJ; Friedlos F
Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
Wibe E
Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
[TBL] [Abstract][Full Text] [Related]
18. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
19. Protein accumulation in lethally damaged cells after treatment with cis-dichlorodiammineplatinum (II): lack of temporal correlation between drug effect and inhibition of spheroid volume growth.
Nordal AK; Juul NO; Pettersen EO
Anticancer Res; 1992; 12(2):305-11. PubMed ID: 1580548
[TBL] [Abstract][Full Text] [Related]
20. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
